Dr Herbst on the Evolution of EGFR Inhibition in Lung Cancer
Roy S. Herbst, MD, PhD, discusses advances in EGFR inhibition throughout the past several decades in patients with lung cancer.
Related Articles
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis – Intellia Therapeutics
The Investor Relations website contains information about Intellia Therapeutics’s business for stockholders, potential investors, and financial analysts.
Welcome! You are invited to join a meeting: Understanding Neuropathy. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: Understanding Neuropathy. After registering, you will receive a confirmation email about joining the meeting.
Intratumoral vidutolimod in combination with PD-1 blockade in locoregionally advanced melanoma
Combinatorial immunotherapy may improve the efficacy of neoadjuvant checkpoint inhibitors in locoregionally advanced melanoma. In this issue of Cancer Cell, Davar and colleagues report a…
Amivantamab/Lazertinib Combo Approaches EU Approval in EGFR+ Advanced NSCLC
The EMA’s CHMP has issued a positive opinion regarding the use of amivantamab plus lazertinib in select patients with EGFR+ non–small cell lung cancer.
Adverse Event Management: Amivantamab
Hatim Husain, MD, discusses how the implementation of proactive prophylaxis strategies for patients taking amivantamab, including prophylactic antibiotics, good skin hygiene, and insights from the…
FDA Approves Revuforj for Relapsed or Refractory Acute Leukemia With a KMT2A Translocation
The FDA approved revumenib (Revuforj, Syndax), a menin inhibitor, for relapsed or refractory acute leukemia with a lysine methyltransferase 2A gene (KMT2A) translocation in adult…
Harnessing Family Connections to Prevent Hereditary Cancers : Oncology Times
An abstract is unavailable.
PreCancer Atlas Collection: From Biology to Cancer Interception | Cancer Prevention Research | American Association for Cancer Research
Developed to facilitate a better understanding across the prevention field of needed near-term next steps and long-term future directions to fully realize
Guidelines for Patients Details
Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.
